Data / Form D filings / Bone Biologics Corp
Bone Biologics Corp: Form D filings
Bone Biologics Corp, a biotechnology company in Burlington, MA, filed 5 Form D notices with the SEC between 2016 and 2023. The latest, on November 29, 2023, reports $729,000 sold of a $729,000 offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2 BURLINGTON WOODS DRIVE, STE 100, Burlington, MA, 01803
- Phone
- (781) 552-4452
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1419554
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 29, 2023 | New notice | $729,000 | $729,000 | 4 | Nov 16, 2023 | sec.gov | |
| Jul 23, 2018 | New notice | $5,869,979 | $5,869,979 | 4 | Jul 16, 2018 | sec.gov | |
| Mar 30, 2018 | Amendment | $10,000,000 | $1,900,000 | $8,100,000 | 2 | Aug 18, 2017 | sec.gov |
| Aug 30, 2017 | New notice | $10,000,000 | $1,400,000 | $8,600,000 | 2 | Aug 18, 2017 | sec.gov |
| Mar 23, 2016 | New notice | $4,500,000 | $0 | $4,500,000 | 3 | Feb 29, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Don R. Hankey | Director | |
| Deina H. Walsh | Executive Officer | |
| Siddhesh R. Angle | Director | |
| Bruce R. Stroever | Director | |
| Erick R. Lucera | Director | |
| Jeffrey Frelick | Executive Officer |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Nov 27, 2023 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Bone Biologics Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.